Revive Therapeutics Ltd. (RVV.CN)
CAD 0.01
(-50.0%)
CAD 0.01
(-50.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CAD | -100.0% |
| 2022 | 85.21 Thousand CAD | -61.21% |
| 2021 | 219.69 Thousand CAD | -32.97% |
| 2020 | 327.73 Thousand CAD | -17.21% |
| 2019 | 395.84 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 60 Thousand CAD | 0.0% |
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q1 | 60 Thousand CAD | -29.59% |
| 2023 Q3 | - CAD | -100.0% |
| 2022 Q2 | 156.04 Thousand CAD | -17.4% |
| 2022 Q3 | 121.51 Thousand CAD | -22.13% |
| 2022 FY | 85.21 Thousand CAD | -61.21% |
| 2022 Q4 | 85.21 Thousand CAD | -29.87% |
| 2022 Q1 | 188.91 Thousand CAD | -14.01% |
| 2021 Q4 | 219.69 Thousand CAD | -11.68% |
| 2021 FY | 219.69 Thousand CAD | -32.97% |
| 2021 Q1 | 302.69 Thousand CAD | -7.64% |
| 2021 Q2 | 276.38 Thousand CAD | -8.69% |
| 2021 Q3 | 248.74 Thousand CAD | -10.0% |
| 2020 Q2 | 354.22 Thousand CAD | -5.74% |
| 2020 Q3 | 331.55 Thousand CAD | -6.4% |
| 2020 Q4 | 327.73 Thousand CAD | -1.15% |
| 2020 FY | 327.73 Thousand CAD | -17.21% |
| 2020 Q1 | 375.8 Thousand CAD | -5.06% |
| 2019 Q1 | 409.63 Thousand CAD | 0.0% |
| 2019 Q4 | 395.84 Thousand CAD | 5.65% |
| 2019 Q3 | 374.66 Thousand CAD | -3.02% |
| 2019 FY | 395.84 Thousand CAD | 0.0% |
| 2019 Q2 | 386.33 Thousand CAD | -5.69% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | - CAD | NaN% |
| Ayurcann Holdings Corp. | 129.01 Thousand CAD | 100.0% |
| Blueberries Medical Corp. | 11.04 Thousand CAD | 100.0% |
| The BC Bud Corporation | - CAD | NaN% |
| BioNxt Solutions Inc. | - CAD | NaN% |
| CordovaCann Corp. | 3.31 Million CAD | 100.0% |
| Christina Lake Cannabis Corp. | 4.48 Million CAD | 100.0% |
| Captor Capital Corp. | 5.47 Million CAD | 100.0% |
| City View Green Holdings Inc. | - CAD | NaN% |
| 1CM Inc. | 4.14 Million CAD | 100.0% |
| Global Hemp Group Inc. | 3.55 Million CAD | 100.0% |
| Greenway Greenhouse Cannabis Corporation | 7.37 Million CAD | 100.0% |
| IM Cannabis Corp. | 394 Thousand CAD | 100.0% |
| Lobe Sciences Ltd. | - CAD | NaN% |
| Maple Leaf Green World Inc. | - CAD | NaN% |
| Mountain Valley MD Holdings Inc. | - CAD | NaN% |
| Nextleaf Solutions Ltd. | 384.69 Thousand CAD | 100.0% |
| Ovation Science Inc. | 18.26 Thousand CAD | 100.0% |
| Pharmadrug Inc. | - CAD | NaN% |
| Captiva Verde Wellness Corp. | - CAD | NaN% |
| RAMM Pharma Corp. | 179.76 Thousand CAD | 100.0% |
| RIV Capital Inc. | 144.15 Million CAD | 100.0% |
| Red White & Bloom Brands Inc. | 21.42 Million CAD | 100.0% |
| SLANG Worldwide Inc. | 3.16 Million CAD | 100.0% |
| 1933 Industries Inc. | 12.57 Million CAD | 100.0% |
| Red Light Holland Corp. | 291.08 Thousand CAD | 100.0% |
| Top Strike Resources Corp. | 1.7 Million CAD | 100.0% |
| Xebra Brands Ltd. | - CAD | NaN% |
| Adastra Holdings Ltd. | 147.51 Thousand CAD | 100.0% |